Literature DB >> 19381781

Association of -394C>G and -420C>G polymorphisms in the RETN gene with T2DM and CHD and a new potential SNP might be exist in exon 3 of RETN gene in Chinese.

Shuguang Chi1, Cailian Lan, Sizhong Zhang, Hekun Liu, Xizhen Wang, Yuanzhong Chen, Xuexiang Chen, Suyun Chen, Wei Zhang.   

Abstract

Genetic variations of the human RETN gene are associated with metabolic phenotypes, including obesity, insulin sensitivity, diabetes, and coronary heart disease (CHD). There are few studies of two gene variants, -394C>G and -420C>G, in Chinese population. This study investigated the distribution of RETN gene, single nucleotide polymorphisms (SNPs), in Chinese Han population and the association of the polymorphisms with type 2 diabetes mellitus (T2DM) and CHD. In a population-based, case-control genetic association study, a total of 961 subjects were recruited from the community, including 318 T2DM patients, 273 CHD patients, and 370 unrelated healthy control individuals. Serum lipid levels were detected. Two SNPs of RETN gene, -394C>G and -420C>G, were genotyped by PCR-RFLP. Unknown Polymorphisms were screened with the technique of denaturing high performance liquid chromatography (DHPLC). The frequencies of RETN -394G allele in T2DM group, CHD group, and control group were 0.3066, 0.3555, and 0.3481, respectively, which are met with the Hardy-Weinberg equilibrium. There is a significant difference of the comparison of sex in T2DM group of RETN gene SNP-394C>G (P < 0.05). Compared with controls, there was no significant difference in the distribution of genotypes and allele frequencies of -394C>G polymorphic site in T2DM patients and CHD patients, respectively. No direct association was found between the -394C>G polymorphism and T2DM or CHD. The frequencies of RETN -420G allele in T2DM group, CHD group, and control group were 0.4009, 0.3725, and 0.3859, respectively, which are met with the Hardy-Weinberg equilibrium. The frequencies of RETN -420G allele in T2DM groups and control groups of Chinese population are significantly different from those in European population (0.40 vs. 0.27, 0.39 vs. 0.26) (P < 0.01). Compared with controls, there was no significant difference in distribution of genotypes and allele frequencies of -420C>G polymorphic site in T2DM patients and CHD patients, respectively. No direct association was found between the -420C>G polymorphism and T2DM or CHD. In addition, we found new potential SNP +593G>C in exon 3 of RETN gene using DHPLC. The RETN gene exhibits sex and ethnic differences. +593G>C of RETN gene might be a new potential SNP in exon 3 of RETN gene. Association between SNP -394C>G and -420C>G of RETN gene with T2DM and CHD in Chinese needs more exploration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19381781     DOI: 10.1007/s11010-009-0097-2

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  33 in total

Review 1.  Inflammatory pathways in atherosclerosis and acute coronary syndromes.

Authors:  J Plutzky
Journal:  Am J Cardiol       Date:  2001-10-18       Impact factor: 2.778

2.  Cross-sectional associations of resistin, coronary heart disease, and insulin resistance.

Authors:  Mary Susan Burnett; Joseph M Devaney; Remi J Adenika; Robert Lindsay; Barbara V Howard
Journal:  J Clin Endocrinol Metab       Date:  2005-10-25       Impact factor: 5.958

3.  Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans.

Authors:  D B Savage; C P Sewter; E S Klenk; D G Segal; A Vidal-Puig; R V Considine; S O'Rahilly
Journal:  Diabetes       Date:  2001-10       Impact factor: 9.461

4.  Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

Authors:  A Festa; R D'Agostino; G Howard; L Mykkänen; R P Tracy; S M Haffner
Journal:  Circulation       Date:  2000-07-04       Impact factor: 29.690

5.  Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes.

Authors:  Aya Fujinami; Hiroshi Obayashi; Kiyoe Ohta; Toshiko Ichimura; Masataka Nishimura; Hidehito Matsui; Yuji Kawahara; Masahiro Yamazaki; Masakazu Ogata; Goji Hasegawa; Naoto Nakamura; Toshikazu Yoshikawa; Koji Nakano; Mitsuhiro Ohta
Journal:  Clin Chim Acta       Date:  2004-01       Impact factor: 3.786

6.  Serum resistin level in essential hypertension patients with different glucose tolerance.

Authors:  J-L Zhang; Y-W Qin; X Zheng; J-L Qiu; D-J Zou
Journal:  Diabet Med       Date:  2003-10       Impact factor: 4.359

7.  Comparative studies of resistin expression and phylogenomics in human and mouse.

Authors:  Rong-Ze Yang; Qing Huang; Aihua Xu; John C McLenithan; Jonathan A Eisen; Alan R Shuldiner; Serhan Alkan; Da-Wei Gong; Jonathan A Eison
Journal:  Biochem Biophys Res Commun       Date:  2003-10-24       Impact factor: 3.575

8.  Association of Resistin Gene 3'-Untranslated Region EX4-44G-->A Polymorphism with Obesity- and Insulin-Related Phenotypes in Turkish Type 2 Diabetes Patients.

Authors:  Belgin Susleyici Duman; Penbe Cagatay; Husrev Hatemi; Melek Ozturk
Journal:  Rev Diabet Stud       Date:  2007-05-10

9.  Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators.

Authors:  Lisa Patel; Amy C Buckels; Ian J Kinghorn; Paul R Murdock; Joanna D Holbrook; Christopher Plumpton; Colin H Macphee; Stephen A Smith
Journal:  Biochem Biophys Res Commun       Date:  2003-01-10       Impact factor: 3.575

Review 10.  An inflammatory cascade leading to hyperresistinemia in humans.

Authors:  Michael Lehrke; Muredach P Reilly; Segan C Millington; Nayyar Iqbal; Daniel J Rader; Mitchell A Lazar
Journal:  PLoS Med       Date:  2004-11-30       Impact factor: 11.069

View more
  5 in total

Review 1.  Gene-gene, gene-environment, gene-nutrient interactions and single nucleotide polymorphisms of inflammatory cytokines.

Authors:  Amina Nadeem; Sadaf Mumtaz; Abdul Khaliq Naveed; Muhammad Aslam; Arif Siddiqui; Ghulam Mustafa Lodhi; Tausif Ahmad
Journal:  World J Diabetes       Date:  2015-05-15

2.  Resistin polymorphims, plasma resistin levels and obesity in Tunisian volunteers.

Authors:  Nesrine Zayani; Haithem Hamdouni; Imen Boumaiza; Ons Achour; Fadoua Neffati; Asma Omezzine; Mohamed Fadhel Najjar; Ali Bouslama
Journal:  J Clin Lab Anal       Date:  2017-04-10       Impact factor: 2.352

3.  Resistin - 420 C/G polymorphism and serum resistin level in Iranian patients with gestational diabetes mellitus.

Authors:  Mohammad Ali Takhshid; Zinab Zare
Journal:  J Diabetes Metab Disord       Date:  2015-04-28

4.  Novel KIF6 polymorphism increases susceptibility to type 2 diabetes mellitus and coronary heart disease in Han Chinese men.

Authors:  Ge Wu; Gui-Bin Li; Bin Dai; Dong-Qing Zhang
Journal:  J Diabetes Res       Date:  2014-12-31       Impact factor: 4.011

5.  Human resistin and the RELM of Inflammation in diabesity.

Authors:  Fatima Al Hannan; Kevin Gerard Culligan
Journal:  Diabetol Metab Syndr       Date:  2015-06-18       Impact factor: 3.320

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.